Show simple item record

Authordc.contributor.authorMendoza Torres, Evelyn 
Authordc.contributor.authorRiquelme, Jaime A. 
Authordc.contributor.authorVielma, Alejandra 
Authordc.contributor.authorSagredo, Andrea Ramirez 
Authordc.contributor.authorGabrielli, Luigi 
Authordc.contributor.authorBravo Sagua, Roberto 
Authordc.contributor.authorJalil Milad, Jorge 
Authordc.contributor.authorRothermel, Beverly A. 
Authordc.contributor.authorSánchez, Gina 
Authordc.contributor.authorOcaranza, María Paz 
Authordc.contributor.authorLavandero González, Sergio
Admission datedc.date.accessioned2019-03-18T12:03:13Z
Available datedc.date.available2019-03-18T12:03:13Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationPharmacological Research, Volumen 135,
Identifierdc.identifier.issn10961186
Identifierdc.identifier.issn10436618
Identifierdc.identifier.other10.1016/j.phrs.2018.07.022
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/167565
Abstractdc.description.abstract© 2018 Elsevier Ltd Angiotensin-(19), a peptide of the non-classical renin angiotensin system, has been shown to prevent and revert hypertension and cardiac hypertrophy. We hypothetized that systemic delivery of angiotensin-(1–9) following myocardial infarction will also be protective and extend to provide protection during reperfusion of the ischemic heart. Adult Sprague Dawley rats were subjected to left anterior descending artery ligation and treated with angiotensin-(1–9) via osmotic mini-pump for 2 weeks in the presence or absence of Mas receptor or AT2R antagonists (A779 and PD123319, respectively). Myocardial death and left ventricular function were evaluated after infarction. Infarct size and functional parameters were determined in isolated rat hearts after global ischemia/reperfusion in the presence of angiotensin-(1–9) plus receptor antagonists or Akt inhibitor at reperfusion. in vitro, neonatal rat ventricular cardiomyocytes underwent simulated ischemia/reperfusion and angi
Lenguagedc.language.isoen
Publisherdc.publisherAcademic Press
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourcePharmacological Research
Keywordsdc.subject2,3,5-Triphenyltetrazolium chloride (CID: 9283)
Keywordsdc.subject2-deoxy-D-glucose (CID: 108223)
Keywordsdc.subjectA779 (CID: 10169886)
Keywordsdc.subjectAkt inhibitor VIII (CID: 10196499)
Keywordsdc.subjectAngiotensin type 2 receptor
Keywordsdc.subjectAngiotensin-(1–9)
Keywordsdc.subjectAngiotensin-(1–9) (CID: 71745056)
Keywordsdc.subjectCardioprotection
Keywordsdc.subjectHeparin (CID: 772)
Keywordsdc.subjectisc
Títulodc.titleProtection of the myocardium against ischemia/reperfusion injury by angiotensin-(1–9) through an AT2R and Akt-dependent mechanism
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile